Related Articles
Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cells
Anthracycline‑induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment (Review)
BNP as a marker for early prediction of anthracycline‑induced cardiotoxicity in patients with breast cancer
Targeted therapy in HER2‑positive breast cancer (Review)
Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancer